KHAI Ventures today announced it entered into an exclusive licensing agreement with Futureheal, securing the sole rights to develop, market, and distribute Futureheal’s proprietary pediatric medical dataset across North, Central, and South America.

Through this strategic partnership, KHAI Ventures gains unrestricted commercial and research rights within the Americas. KHAI Ventures plans to leverage the dataset to support its growing portfolio of healthcare AI companies to train, strengthen, and further validate their clinical AI/ML predictive models. Additionally, KHAI intends to launch multiple companies aimed at delivering clinical Data as a Service solution.

The dataset includes fully de-identified longitudinal medical records representing approximately 17 million unique pediatric patients across more than 27 hospitals. Combining both structured and unstructured data, the dataset features comprehensive clinical notes, medical imaging, laboratory results, and historical medical records. Under the agreement, Futureheal will handle all rigorous data de-identification processes and has the option to scale the dataset further, while KHAI Ventures will manage commercialization, translation, and data harmonization tailored for American markets.

Read the full press release at: https://www.prweb.com/releases/khai-ventures-secures-exclusive-commercial-rights-to-comprehensive-17-million-pediatric-patient-dataset-to-support-its-healthcare-ai-portfolio-302838625.html